M
Midwest Allergy Sinus Asthma, SC | Normal, IL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
PF-04965842
Ruxolitinib
PF04965842
MK-7264-027
MK-7264
Dupilumab
Povorcitinib
Gefapixant
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 7 total trials
This study is being conducted to evaluate the efficacy and safety of povorcitinib in adults with CSU that is inadequately controlled using SOC treatm...
Enrolling
Angioedema
Hives
Drug: Placebo
Drug: Povorcitinib
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 200 mg
Drug: Abrocitinib 100 mg
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema (CH...
Active, not recruiting
Hand Eczema
Drug: Ruxolitinib cream
Drug: Vehicle
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems